The Germany legal cannabis market size was estimated at USD 2.04 billion in 2024 and is expected to reach USD 9.66 billion by 2033, growing at a CAGR of 18.9% from 2025 to 2033. Factors such as the growing adoption of cannabis for the treatment of chronic diseases, affirmative legal advancements in the country, increasing research activities on its therapeutic use, and growing adoption and introduction of CBD cosmetic products drive market growth. For instance, in September 2023, Cronos Group Inc. launched the medical brand PEACE NATURALS in Germany. In July, the company signed a distribution agreement with Cansativa Group, a distributor of medical cannabis in Germany.
Furthermore, favorable government initiatives and rising demand for CBD-infused products in Germany fuel the market growth. For instance, the general European Union (EU) position has been adopted by Germany, which allows some form of reasonable sale of non-food CBD products as long as they contain no more than 0.2% delta-9 tetrahydrocannabinol (THC). Moreover, Küsten CBD, a German CBD cosmetics company, offers CBD cosmetics, including Cooling gel for accompanying symptoms of muscle tension, osteoarthritis, and bruises; Warming gel for joint pain and back pain; Tattoo/Body Lotion for dry skin prone to acne and neurodermatitis; Body oil/massage oil (Rose Dream) for daily body care, and Facial Fluid (Anti-Aging - Lime) for dry and sensitive skin.
Moreover, rising prevalence of chronic conditions such as s diabetes, cancer, and neurological conditions and growing research activities and clinical trials in Germany propel the market growth. For instance, in October 2023, Avextra, a biopharmaceutical company, moved forward with a double-blind Phase 2 clinical trial for the use of Belcanto in the treatment of cancer patients in palliative care. This medicine received approval from The German Federal Institute for Drugs and Medical Devices (BfArM) and the responsible ethics committees, with the first patient expected to be dosed in December 2023.
This product will be delivered within 2 business days.
Furthermore, favorable government initiatives and rising demand for CBD-infused products in Germany fuel the market growth. For instance, the general European Union (EU) position has been adopted by Germany, which allows some form of reasonable sale of non-food CBD products as long as they contain no more than 0.2% delta-9 tetrahydrocannabinol (THC). Moreover, Küsten CBD, a German CBD cosmetics company, offers CBD cosmetics, including Cooling gel for accompanying symptoms of muscle tension, osteoarthritis, and bruises; Warming gel for joint pain and back pain; Tattoo/Body Lotion for dry skin prone to acne and neurodermatitis; Body oil/massage oil (Rose Dream) for daily body care, and Facial Fluid (Anti-Aging - Lime) for dry and sensitive skin.
Moreover, rising prevalence of chronic conditions such as s diabetes, cancer, and neurological conditions and growing research activities and clinical trials in Germany propel the market growth. For instance, in October 2023, Avextra, a biopharmaceutical company, moved forward with a double-blind Phase 2 clinical trial for the use of Belcanto in the treatment of cancer patients in palliative care. This medicine received approval from The German Federal Institute for Drugs and Medical Devices (BfArM) and the responsible ethics committees, with the first patient expected to be dosed in December 2023.
Germany Legal Cannabis Market Report Segmentation
This report forecasts revenue growth and provides at country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the Germany legal cannabis market report based on source, derivatives, and end use:Source Outlook (Revenue, USD Million, 2021-2033)
- .Hemp
- Hemp oil
- Industrial Hemp
- Marijuana
- Flower
- Oil and Tinctures
Derivatives Outlook (Revenue, USD Million, 2021-2033)
- CBD
- THC
- Others
End Use Type Outlook (Revenue, USD Million, 2021-2033)
- Industrial Use
- Medical Use
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Post Traumatic Stress Disorder (PTSD)
- Cancer
- Migraines
- Epilepsy
- Alzheimers's
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Tourettes
- Diabetes
- Parkinson's
- Glaucoma
- Others
- Recreational Use
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Germany Legal Cannabis Market Variables, Trends, and Scope
Chapter 4. Germany Legal Cannabis Market: Segment Analysis, by Source, 2021-2033 (USD Million)
Chapter 5. Germany Legal Cannabis Market: Segment Analysis, by Derivative, 2021-2033 (USD Million)
Chapter 6. Germany Legal Cannabis Market: Segment Analysis, by End Use, 2021-2033 (USD Million)
Chapter 7. Germany Legal Cannabis Market: Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this Germany Legal Cannabis market report include:- The Cronos Group
- Organigram Holding, Inc
- Tilray Brands
- Canopy Growth Corporation
- Aurora Cannabis
- SynBiotic
- Cansativa GmbH
- DEMECAN
- Four 20 Pharma
- Avextra Pharma GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 2.04 Billion |
| Forecasted Market Value ( USD | $ 9.66 Billion |
| Compound Annual Growth Rate | 18.9% |
| Regions Covered | Germany |
| No. of Companies Mentioned | 11 |
